Eagle Health Investments LP Ultragenyx Pharmaceutical Inc. Transaction History
Eagle Health Investments LP
- $407 Million
- Q4 2024
A detailed history of Eagle Health Investments LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Eagle Health Investments LP holds 627,600 shares of RARE stock, worth $24.9 Million. This represents 6.49% of its overall portfolio holdings.
Number of Shares
627,600
Previous 561,700
11.73%
Holding current value
$24.9 Million
Previous $31.2 Million
15.38%
% of portfolio
6.49%
Previous 5.92%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
345Shares Held
86.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$222 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$170 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$108 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$99.6 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.78B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...